首页> 外文OA文献 >The FDA's failure to address the lack of generalisability of antidepressant efficacy trials in product labelling

【2h】

The FDA's failure to address the lack of generalisability of antidepressant efficacy trials in product labelling

机译：FDA未能解决产品标签中抗抑郁药效试验的缺乏可恒定性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Mark Zimmerman;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The FDA's failure to address the lack of generalisability of antidepressant efficacy trials in product labelling [J] . Mark Zimmerman International Journal of Energy, Information and Communications . 2016,第6期

机译：FDA无法解决产品标签中抗抑郁药功效试验缺乏通用性的问题
2. The FDA's failure to address the lack of generalisability of antidepressant efficacy trials in product labelling [J] . Zimmerman Mark The British journal of psychiatry : . 2016,第6期

机译：FDA无法解决产品标签中抗抑郁药功效试验缺乏通用性的问题
3. Juries Trump FDA in Writing Drug Labels; FDA Grants Clinical Trial Permission for Human Embryonic Stem Cells; Alerts Issued for Two Biotechnology Products; Japanese Rheumatoid Arthritis Drug Approved in Europe; FDA Criticizes Humira Ad; Amgen's BLA for Bone Drug Accepted; Rules for Claiming Health Benefits from Food and Supplements [J] . Biotechnology Law Report . 2009,第2期

机译：陪审团特朗普FDA撰写药品标签； FDA授予人类胚胎干细胞临床试验许可；两种生物技术产品发出警报；日本在欧洲批准了类风湿关节炎药物； FDA批评Humira广告；接受了安进公司的骨药物BLA；从食品和补品中获取健康益处的规定
4. UK Pesticides Safety Directorate efficacy data requirements and guidance on trials design for mating disruption pheromone products (and other semiochemicals) [C] . S M Mattock International Plant Protection Congress . 2007

机译：英国农药安全监管有效性数据要求和对配合中断信息素产品的试验设计指导（以及其他半化酶）
5. Development and impact of a food label education intervention on food label knowledge, self-efficacy and stage of change among Latinos: A randomized community trial. [D] . Haldeman, Lauren Ann. 2001

机译：食品标签教育干预措施对拉丁裔拉丁美洲人食品标签知识，自我效能感和变化阶段的发展及其影响：一项随机社区试验。
6. Failure to address potential bias in non-randomised controlled clinical trials may cause lack of evidence on patient-reported outcomes: a method study [O] . Frank Peinemann, Alexander Michael Labeit, Christian Thielscher, 2014

机译：方法研究未能解决非随机对照临床试验中的潜在偏倚可能导致缺乏患者报告的结果的证据
7. Hospitalisation Due to Heart Failure with Gliptins and Universal Label Change (FDA)-Still Justified? A Meta-Analysis of 5 Cardiovascular Outcomes Trials [O] . Samit Ghosal, Awadhesh Kumar Singh 2018

机译：由于灵敏度和通用标签变化（FDA）的心力衰竭，住院治疗 - 证明了吗？荟萃分析5个心血管结果试验
8. Pesticide Regulation (PR) Notice 96-4. Notice to Manufacturers, Producers,Formulators, and Registrants of Pesticide Products. Label Statements Involving Product Efficacy and Potential for Harm to Property [R] . 1996

机译：农药监管（pR）公告96-4。关于农药产品的制造商，生产商，配方设计师和注册人的通知。涉及产品功效的标签声明和对财产造成危害的可能性

The FDA's failure to address the lack of generalisability of antidepressant efficacy trials in product labelling

著录项

相似文献

相关主题

期刊订阅